Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hata, K.
Right arrow Articles by Miyazaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hata, K.
Right arrow Articles by Miyazaki, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 6, No. 4, 319-323, April 2000
© 2000 European Society of Human Reproduction and Embryology


Ovary and oogenesis

Expression of TP and TIE2 genes in normal ovary with corpus luteum and in ovarian cancer: correlation with ultrasound-derived peak systolic velocity

Kohkichi Hata1,3, Ritsuto Fujiwaki1, Kentaro Nakayama1,2, Manabu Fukumoto2 and Kohji Miyazaki1

1 Department of Obstetrics and Gynecology, Shimane Medical University, Izumo 693-8501, and 2 Department of Pathology, Institute of Aging and Cancer, Tohoku University, Sendai 980-8575, Japan

Abstract

Transvaginal colour and pulsed Doppler ultrasonography analyses of blood flow velocity have indicated that intra-tumoral peak systolic velocity (PSV) is a good indicator of ovarian malignancy. Therefore, we examined whether there was an association between the expression of angiogenic genes, e.g. thymidine phosphorylase (TP) and TIE2 and the PSV of blood flow in normal and cancerous ovaries. Initially, 40 patients were examined by transvaginal ultrasonography and 23 ovaries were surgically removed; 14 were normal with corpora lutea (CL) and nine showed ovarian cancer. The ovarian tissue was dissected according to areas of high blood velocity and gene expression was examined using the reverse transcriptase–polymerase chain reaction (RT–PCR). No significant differences were found between PSV in the normal ovary with CL and ovarian cancer (P = 0.95). TP gene expression was significantly higher in ovarian cancer than in normal ovary with CL (P = 0.02), while TIE2 gene expression was not significantly different (P = 0.186). There was a significant correlation between TIE2 gene expression and PSV in the normal ovary with CL (r = 0.633, P = 0.015), while TP expression was significantly correlated with the PSV in ovarian cancer (r = 0.757, P = 0.018). These results indicate that there is a biological difference between physiological and pathological angiogenesis, TIE2 having a physiological role and TP being involved in pathological angiogenesis.

gene expression/pulsed Doppler spectral analysis/RT–PCR/thymidine phosphorylase/TIE2

Notes

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Hata, R. Fujiwaki, K. Nakayama, and K. Miyazaki
Expression of the Endostatin Gene in Epithelial Ovarian Cancer
Clin. Cancer Res., August 1, 2001; 7(8): 2405 - 2409.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Hata, Y. Takebayashi, S. Akiba, R. Fujiwaki, K. Iida, K. Nakayama, S. Nakayama, M. Fukumoto, and K. Miyazaki
Expression of the adrenomedullin gene in epithelial ovarian cancer
Mol. Hum. Reprod., October 1, 2000; 6(10): 867 - 872.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.